Merck Serono

Serono was originally the largest biopharmaceutical company in Europe. It was acquired by Merck in 2006 and is now a pharmaceutical subsidiary of Merck, renamed Merck Serono.Merck Serono discovers, develops, manufactures, and commercializes prescription drugs, focusing on various therapeutic areas, including oncology, immuno-oncology, immunology, multiple sclerosis, fertility, endocrinology, biosimilars, and neglected diseases. The drugs developed by Merck Serono primarily target neurodegenerative diseases (such as multiple sclerosis), colorectal cancer, head and neck cancer, and every stage of the fertility cycle.